Rasmus Just

Rasmus Just, PhD, MBA, is a seasoned professional with extensive experience in the biomedical and pharmaceutical sectors. Currently serving as Global Head of Business Development at ALK since January 2018, Rasmus leads initiatives in allergy-focused business development, including partnerships, licensing, and M&A. As a co-founder of Optoceutics, involvement encompasses the development of innovative light therapy for neurodegenerative diseases. Additionally, Rasmus oversees the exclusive distribution of X3bar in Scandinavia through Jaquish Biomedical and chairs the board of OsteoStrong in Denmark, focusing on bone health technology. Rasmus also chairs VJACK Ventures, an angel investment fund targeting non-pharmaceutical health solutions. A prior role at Zealand Pharma involved various leadership positions, including Director of Business Development and Innovation Sourcing, emphasizing peptide drug development. Rasmus holds a PhD in Molecular Pharmacology from the University of Copenhagen, an MBA from AVT Business School, and a Master's degree in Biology from the University of Copenhagen.